Dove Bunkin-Thomas

Dove Bunkin-Thomas currently serves as the Executive Director of Medical Writing and Regulatory Execution at Apogee Therapeutics, beginning in September 2023. Prior to this role, Dove held various positions at Amgen from 1999 to 2023, including Director of Global Regulatory Affairs, where oversight of vendor management and regulatory documentation was key. Responsibilities also included leading efforts for process improvement and managing large-scale updates to the Document Management System. With more than 20 years of experience in the pharmaceutical industry and extensive expertise in regulatory writing, Dove has contributed to numerous regulatory submissions across multiple therapeutic areas. Educational qualifications include a Master of Science in Nutritional Sciences from Rutgers University and dual Bachelor's degrees in Psychology and Biology from UC San Diego.